Legemiddelindustrien

What Legemiddelindustrien does

Legemiddelindustrien (LMI) is the trade association for the pharmaceutical industry in Norway, headquartered in Oslo. It represents 65 member companies — both Norwegian and foreign-owned — that develop, produce, sell, or market medicines in Norway, collectively accounting for over 80% of national pharmaceutical sales. LMI is affiliated with Næringslivets Hovedorganisasjon (NHO) and NHO Geneo, and is a member of the European federation EFPIA and the international federation IFPMA, giving it formal standing in Norwegian employer policy and international pharmaceutical advocacy.

LMI's core offerings are member services rather than commercial products. The association delivers the Digitalis extranet (a member-only portal carrying national and EU regulatory news, EFPIA information, and event calendars), LMI TV (a video platform featuring member profiles), a mandatory training and certification program for pharmaceutical consultants (Legemiddelkonsulentutdanning), a concept-approval service for member-sponsored events (Konseptgodkjenninger), the Rådet for legemiddelinformasjon ethics council, and the Verdioverføringer disclosure platform for industry-to-healthcare transfers. Wholly-owned subsidiaries Felleskatalogen AS (pharmaceutical product cataloging) and Nomvec (pharmaceutical verification system) extend the operating footprint.

LMI's revenue is generated primarily through membership fees structured as a fixed component plus a revenue-based component, with reduced fees for low-revenue or pre-commercial companies. Go-to-market is community-led: conferences, general assemblies, working groups, daily newsletters, and policy events such as Arendalsuka and Tilgangskonferansen. LMI's administration is small (16 employees), but the member base represents over 4,500 jobs in Norway and a national pharmaceutical market of approximately 20 billion NOK.

Name

Legemiddelindustrien

Legal name

Legemiddelindustrien (LMI)

Website

https://lmi.no

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Legemiddelindustrien (LMI) is Norway's pharmaceutical industry trade association, representing 65 member companies that account for over 80% of national pharmaceutical sales. It delivers advocacy, regulatory self-management, training, disclosure, and extranet services, and is affiliated with NHO, EFPIA, and IFPMA.

Ownership category

akta.pro rank

Product category

Pharmaceutical Industry Trade Association

NAICS

Professional Organizations (81392), Management Consulting Services (54161)

SIC

Services-Membership Organizations (8600), Services-Management Consulting Services (8742)

akta.pro primary industry

Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

Keywords

• Pharmaceutical industry association
• Trade association services
• Pharmaceutical policy advocacy
• Industry compliance training
• Pharmaceutical disclosure services

Headquarters

HQ city

Oslo

HQ country

Norway

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership fees: LMI's primary revenue comes from membership fees which consist of a fixed fee and a revenue-based portion. Companies with low revenue and pre-commercial companies developing medicines without marketing authorization may receive lower membership fees.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels11 records

Core offering

Legemiddelindustrien is a Norwegian trade association (bransjeforening) for pharmaceutical companies, representing industry interests toward authorities and stakeholders and providing member services such as advocacy, training for pharmaceutical consultants, ethics oversight via Rådet for legemiddelinformasjon, transparency disclosures (Verdioverføringer / Disclosure Norway), and concept approvals (Konseptgodkjenninger). It also operates member-facing channels including the Digitalis intranet and LMI TV, and owns subsidiaries such as Felleskatalogen AS and Nomvec.

Product overview

Legemiddelindustrien (LMI) is a trade association (bransjeforening) for the pharmaceutical industry in Norway, not a product company. LMI provides member services including the Digitalis intranet platform for industry news and regulatory information, education and certification for pharmaceutical consultants, concept approval services for industry-healthcare interactions, and transparency disclosure systems. The association operates subsidiaries Felleskatalogen (product cataloging) and Nomvec (verification system). LMI's members are pharmaceutical companies that develop, produce, sell, or market medicines in Norway.

Differentiator

Problem solved

Functional benefit

Brands

• Digitalis: LMI's member extranet providing access to industry news, documentation, and member services
• LMI TV

Products and services

• LMI Industry Membership

Quantifiable outcome

• 65 member companies representing over 80% of pharmaceutical sales in Norway
• +2 more outcomes

Named customers15 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• Næringslivets Hovedorganisasjon (NHO)coreOthersLMI is affiliated with NHO, Norway's largest business interest organization and leading employer organization. As a member in LMI, one must also be a member in one of NHO's 17 regional associations. All LMI members are affiliated with NHO Geneo, the regional association for health, welfare and upbringing companies.
• NHO GeneocoreOthersAll LMI members are affiliated with NHO Geneo, which is the regional association for health, welfare and upbringing companies in Norway. LMI works closely with NHO Geneo.
• Norsk IndustricoreOthersSome LMI members, especially production companies, are also members of Norsk Industri, NHO's largest regional association. LMI companies with dual membership between NHO Geneo and Norsk Industri pay the same membership fee as those only affiliated with NHO Geneo. LMI works closely with Norsk Industri.
• EFPIA (European Federation of Pharmaceutical Industries and Associations)coreStrategic or Co-development PartnerLMI is a member of EFPIA, the European pharmaceutical industry association that represents pharmaceutical industry operating in Europe. Through EFPIA, LMI is also affiliated with AESGP (Association of the European Self-Care Industry) and Vaccines Europe. LMI's advisors are represented in various working groups in EFPIA.
• IFPMA (International Federation of Pharmaceutical Manufacturers and Traders)coreStrategic or Co-development PartnerLMI is a member of IFPMA, the international pharmaceutical industry association. IFPMA represents the innovative pharmaceutical industry at international level and collaborates closely with all public health actors in the UN system, including WHO, WTO and WIPO. LMI's advisors are represented in various working groups in IFPMA.
• FelleskatalogencoreOthersFelleskatalogen is a subsidiary of LMI, providing pharmaceutical product information and catalogs.
• NomveccoreOthersNomvec is a subsidiary of LMI, operating in the pharmaceutical sector.
• Den Norske LegeforeningminorStrategic or Co-development PartnerLMI collaborates with the Norwegian Medical Association as part of the rules for interaction between healthcare professionals and the pharmaceutical industry.
• Norsk SykepleierforbundminorStrategic or Co-development PartnerLMI collaborates with the Norwegian Nurses Organization as part of the rules for interaction between healthcare professionals and the pharmaceutical industry.
• Norges Farmaceutiske ForeningminorStrategic or Co-development PartnerLMI collaborates with the Norwegian Pharmaceutical Association as part of the rules for interaction between healthcare professionals and the pharmaceutical industry.

Scale indicators13 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• PhRMA (Pharmaceutical Research and Manufacturers of America): The US pharma industry association with the same advocacy and disclosure mandate as LMI but at vastly larger scale and budget. Useful comparability anchor for LMI's policy and ethics function.
• IFPMA (International Federation of Pharmaceutical Manufacturers and Associations): LMI's international-level counterpart, representing innovative pharma to the WHO, WTO, and WIPO. Operates the same trade-association model as LMI but at global scope; LMI holds membership and contributes advisors.
• EFPIA (European Federation of Pharmaceutical Industries and Associations): LMI's direct European umbrella association; EFPIA represents the innovative pharma industry to EU institutions. LMI sits on EFPIA working groups and is channelled through it for Brussels-level policy, making it the closest structural peer at a continental scope.

Direct peers

• vfa (Verband forschender Arzneimittelhersteller, Germany): Germany's research-based pharma industry association. Direct functional peer with the same mix of policy advocacy, self-regulation, and member services; benchmark for mature EU pharma trade association operations.
• LIF (Läkemedelsindustriföreningen, Sweden): Sweden's pharmaceutical industry association. Most direct Nordic peer — same GTM motion (member services, ethics code, FASS-style product information catalog via subsidiary), same regulatory environment, and overlapping cross-border membership.
• Pharmadanmark: Danish pharmaceutical industry association. Nordic peer with comparable member services, advocacy, and self-regulatory functions; small-staff structure analogous to LMI's.
• Pharma Fimea / Finnish Pharma Industry Association: Pharma Industry Finland (PIF), the Finnish equivalent of LMI, representing research-based pharma companies in Finland with advocacy, policy, and ethics functions. Direct Nordic peer.
• LEEM (Les Entreprises du Médicament, France): France's national pharma industry association — same model (member services, lobbying, code of conduct on HCP interactions, transparency disclosure) at materially larger scale. Useful benchmark for LMI's potential trajectory.
• ABPI (Association of the British Pharmaceutical Industry): The UK national pharma industry association with the same mandate as LMI: representation, self-regulation (PMCPA), disclosure of transfers to HCPs, and policy advocacy. Closest functional mirror in a comparable market.

Others

• NHO (Næringslivets Hovedorganisasjon): Norway's confederation of enterprise — LMI's parent affiliation through NHO Geneo. Not a direct competitor but a structural peer as the overarching employer federation that shapes the cross-industry policy environment LMI operates in.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/legemiddelind
• YouTubeyoutube.com/channel/UCC97hSebyT-pIN_n2NeD1KQ
• Facebookfacebook.com/LegemiddelindustrienLMI
• LinkedInlinkedin.com/company/legemiddelindustrien
• Instagraminstagram.com/legemiddelindustrien

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Legemiddelindustrien